Fifth Third Bancorp’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$103K Sell
819
-237
-22% -$29.8K ﹤0.01% 1148
2025
Q1
$117K Buy
1,056
+254
+32% +$28.1K ﹤0.01% 1096
2024
Q4
$109K Sell
802
-2
-0.2% -$273 ﹤0.01% 1120
2024
Q3
$92.6K Buy
804
+88
+12% +$10.1K ﹤0.01% 1204
2024
Q2
$98.6K Buy
716
+92
+15% +$12.7K ﹤0.01% 1150
2024
Q1
$86.1K Buy
624
+32
+5% +$4.41K ﹤0.01% 1168
2023
Q4
$78K Sell
592
-30
-5% -$3.95K ﹤0.01% 1221
2023
Q3
$70K Buy
622
+211
+51% +$23.7K ﹤0.01% 1244
2023
Q2
$38.8K Buy
411
+62
+18% +$5.85K ﹤0.01% 1464
2023
Q1
$35.3K Buy
349
+48
+16% +$4.86K ﹤0.01% 1590
2022
Q4
$36K Sell
301
-15
-5% -$1.79K ﹤0.01% 1472
2022
Q3
$34K Sell
316
-103
-25% -$11.1K ﹤0.01% 1478
2022
Q2
$41K Buy
419
+102
+32% +$9.98K ﹤0.01% 1447
2022
Q1
$30K Buy
317
+69
+28% +$6.53K ﹤0.01% 1658
2021
Q4
$21K Hold
248
﹤0.01% 1844
2021
Q3
$24K Buy
248
+238
+2,380% +$23K ﹤0.01% 1731
2021
Q2
$1K Buy
+10
New +$1K ﹤0.01% 2389
2020
Q2
Sell
-104
Closed -$9K 2183
2020
Q1
$9K Sell
104
-18
-15% -$1.56K ﹤0.01% 1749
2019
Q4
$13K Buy
122
+18
+17% +$1.92K ﹤0.01% 1777
2019
Q3
$9K Sell
104
-896
-90% -$77.5K ﹤0.01% 1821
2019
Q2
$84K Hold
1,000
﹤0.01% 1184
2019
Q1
$88K Buy
1,000
+999
+99,900% +$87.9K ﹤0.01% 1104
2018
Q4
$0 Sell
1
-88
-99% ﹤0.01% 2305
2018
Q3
$11K Sell
89
-77
-46% -$9.52K ﹤0.01% 1803
2018
Q2
$16K Hold
166
﹤0.01% 1742
2018
Q1
$14K Sell
166
-176
-51% -$14.8K ﹤0.01% 1795
2017
Q4
$27K Sell
342
-392
-53% -$30.9K ﹤0.01% 1493
2017
Q3
$45K Sell
734
-225
-23% -$13.8K ﹤0.01% 1321
2017
Q2
$44K Buy
959
+52
+6% +$2.39K ﹤0.01% 1317
2017
Q1
$39K Buy
+907
New +$39K ﹤0.01% 1389
2016
Q4
Sell
-499
Closed -$25K 2251
2016
Q3
$25K Sell
499
-3,507
-88% -$176K ﹤0.01% 1557
2016
Q2
$182K Sell
4,006
-1,031
-20% -$46.8K ﹤0.01% 940
2016
Q1
$199K Sell
5,037
-31
-0.6% -$1.23K ﹤0.01% 919
2015
Q4
$287K Buy
5,068
+3,864
+321% +$219K ﹤0.01% 859
2015
Q3
$48K Sell
1,204
-1,357
-53% -$54.1K ﹤0.01% 1418
2015
Q2
$122K Sell
2,561
-85
-3% -$4.05K ﹤0.01% 1134
2015
Q1
$105K Buy
+2,646
New +$105K ﹤0.01% 1180